Financial Performance - Xilio Therapeutics reported a quarterly loss of $0.16 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.08, and improved from a loss of $0.24 per share a year ago [1] - The company posted revenues of $8.08 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 10.38%, and showing significant growth from year-ago revenues of $2.36 million [2] - Over the last four quarters, Xilio Therapeutics has surpassed consensus EPS estimates two times, but has not beaten consensus revenue estimates [2] Stock Performance - Xilio Therapeutics shares have declined approximately 25.2% since the beginning of the year, contrasting with the S&P 500's gain of 10% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.05 on revenues of $25.56 million, and for the current fiscal year, it is -$0.23 on revenues of $103.74 million [7] - The trend of estimate revisions for Xilio Therapeutics was unfavorable prior to the earnings release, which may impact future stock movements [6] Industry Context - The Medical - Biomedical and Genetics industry, to which Xilio Therapeutics belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could be a useful metric for investors [5]

分组1 - Skechers reported quarterly earnings of $1.13 per share, exceeding the Zacks Consensus Estimate of $0.83 per share, and showing an increase from $0.91 per share a year ago, resulting in an earnings surprise of +36.14% [1] - The company achieved revenues of $2.44 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 4.50%, and up from $2.16 billion year-over-year [2] - Over the last four quarters, Skechers has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] 分组2 - The stock has underperformed the market, losing about 6.3% since the beginning of the year, while the S&P 500 has gained 7.8% [3] - The current consensus EPS estimate for the coming quarter is $0.93 on revenues of $2.53 billion, and for the current fiscal year, it is $3.65 on revenues of $9.67 billion [7] - The Zacks Industry Rank for Shoes and Retail Apparel is currently in the bottom 30% of over 250 Zacks industries, indicating potential challenges for the sector [8]

Group 1: Earnings Performance - Hackett Group reported quarterly earnings of $0.38 per share, matching the Zacks Consensus Estimate, but down from $0.39 per share a year ago [1] - The company posted revenues of $77.63 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 1.30% and up from $75.9 million year-over-year [2] - Over the last four quarters, Hackett Group has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2][3] Group 2: Stock Performance and Outlook - Hackett Group shares have declined approximately 24.2% since the beginning of the year, contrasting with the S&P 500's gain of 7.6% [3] - The company's earnings outlook is crucial for assessing future stock performance, with current consensus EPS estimates at $0.43 for the coming quarter and $1.64 for the current fiscal year [4][7] - The estimate revisions trend for Hackett Group was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Group 3: Industry Context - The Consulting Services industry, to which Hackett Group belongs, is currently ranked in the top 12% of over 250 Zacks industries, suggesting a favorable outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Group 1 - Gossamer Bio reported a quarterly loss of $0.16 per share, better than the Zacks Consensus Estimate of a loss of $0.18, and an improvement from a loss of $0.19 per share a year ago, resulting in an earnings surprise of 11.11% [1] - The company achieved revenues of $9.89 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 167.27%, compared to zero revenues a year ago [2] - Gossamer Bio shares have increased approximately 11.7% since the beginning of the year, outperforming the S&P 500's gain of 0.2% [3] Group 2 - The earnings outlook for Gossamer Bio is mixed, with the current consensus EPS estimate for the upcoming quarter at -$0.18 on revenues of $4.13 million, and -$0.66 on revenues of $26.3 million for the current fiscal year [7] - The Medical - Biomedical and Genetics industry, to which Gossamer Bio belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] Group 3 - Gossamer Bio has surpassed consensus EPS estimates three times over the last four quarters, indicating a positive trend in earnings performance [2] - The estimate revisions trend for Gossamer Bio is currently mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6]

Company Performance - Star Bulk Carriers reported a quarterly loss of $0.07 per share, significantly better than the Zacks Consensus Estimate of a loss of $0.23, and down from earnings of $0.87 per share a year ago, indicating an earnings surprise of 69.57% [1] - The company posted revenues of $230.65 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 9.56%, but down from $259.39 million in the same quarter last year [2] - Over the last four quarters, Star Bulk Carriers has surpassed consensus revenue estimates four times, but has only exceeded consensus EPS estimates once [2] Stock Performance - Star Bulk Carriers shares have increased approximately 9.9% since the beginning of the year, outperforming the S&P 500, which gained only 0.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.32 on revenues of $276.4 million, and for the current fiscal year, it is $1.31 on revenues of $1.05 billion [7] Industry Outlook - The Transportation - Shipping industry, to which Star Bulk Carriers belongs, is currently ranked in the bottom 19% of over 250 Zacks industries, indicating potential challenges ahead [8] - The outlook for the industry can significantly impact the stock's performance, as historical data shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Company Performance - nLight reported a quarterly loss of $0.04 per share, significantly better than the Zacks Consensus Estimate of a loss of $0.18, and an improvement from a loss of $0.17 per share a year ago, representing an earnings surprise of 77.78% [1] - The company posted revenues of $51.67 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 10.37% and up from $44.53 million in the same quarter last year [2] - Over the last four quarters, nLight has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Outlook - nLight shares have declined approximately 21.9% since the beginning of the year, compared to a decline of 4.3% for the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -$0.12 on revenues of $49.67 million, and for the current fiscal year, it is -$0.51 on revenues of $205.63 million [7] Industry Context - The Electronics - Semiconductors industry, to which nLight belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, indicating potential challenges for stocks in this sector [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact nLight's stock performance [5]

Core Insights - UL Solutions Inc. reported quarterly earnings of $0.37 per share, exceeding the Zacks Consensus Estimate of $0.32 per share, and showing an increase from $0.28 per share a year ago, resulting in an earnings surprise of 15.63% [1] - The company achieved revenues of $705 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.16% and up from $670 million year-over-year [2] - UL Solutions Inc. shares have increased approximately 20.2% since the beginning of the year, contrasting with a decline of 3.9% in the S&P 500 [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.47, with projected revenues of $769.66 million, and for the current fiscal year, the EPS estimate is $1.70 on revenues of $3.02 billion [7] - The estimate revisions trend for UL Solutions Inc. is mixed, leading to a Zacks Rank of 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Business - Services industry, to which UL Solutions Inc. belongs, is currently ranked in the top 24% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Another company in the same industry, ABM Industries, is expected to report quarterly earnings of $0.88 per share, reflecting a year-over-year change of +1.2%, with revenues anticipated to be $2.08 billion, up 2.8% from the previous year [9]

Core Viewpoint - Cipher Mining Inc. reported a quarterly loss of $0.11 per share, aligning with the Zacks Consensus Estimate, compared to earnings of $0.13 per share a year ago [1] - The company has shown mixed performance in terms of revenue and earnings estimates over the past quarters [2][6] Financial Performance - Cipher Mining's revenues for the quarter ended March 2025 were $48.96 million, missing the Zacks Consensus Estimate by 2.48%, but showing an increase from $48.14 million year-over-year [2] - The company has surpassed consensus revenue estimates only once in the last four quarters [2] Stock Performance - Cipher Mining shares have declined approximately 35.8% since the beginning of the year, contrasting with the S&P 500's decline of 3.9% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.13 on revenues of $51.68 million, and for the current fiscal year, it is -$0.39 on revenues of $255.36 million [7] - The trend of estimate revisions for Cipher Mining is mixed, which may change following the recent earnings report [6] Industry Context - The Technology Services industry, to which Cipher Mining belongs, is currently ranked in the top 24% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]